CELMoDs Tomorrow

A panel of experts explore the potential of next-generation #myeloma treatments, focusing on Cereblon E3 ligase modulators (CELMoDs) and the critical need for equitable patient access. The panel includes: Dana…

Immunomodulators (IMDs) Today

A panel of experts discuss the bedrock therapy in multiple myeloma immunomodulators (IMDs). The panel includes: Jenny Ahlstrom – Founder and Chief Executive Officer, Healthtree Foundation Diane Moran – Business…

Tailored Multiple Myeloma Care

A panel of experts discuss strategies for how to best support multiple myeloma patients and their families during treatment. The panel includes: Diane Moran – Business Relationship Management, International Myeloma…

Multiple Myeloma Community Barriers

A panel of experts discuss the barriers multiple myeloma patients face when receiving care in community-based settings. The panel includes: Jenny Ahlstrom – Founder and Chief Executive Officer, Healthtree Foundation…

Peer Insights | The Power of Patient-Centered Care

https://vimeo.com/1007534672 What’s important to know about patient-centered care? PEN’s Aïcha Diallo discusses key aspects and benefits of patient-centered care, the impact of patients engaging in shared decision-making, and treatment adherence in relation…

Share On:

Facebook
Twitter
LinkedIn